As presented in Table 1, critical baseline data were analyzed, including age, gender, ALT and AST levels, ALBI, Child-Pugh score, vascular invasion, AFP and PIVKA-II levels, the number and size of tumors in the liver, metastasis, CNLC stage, hepatitis and cirrhosis. The gene discussed is GPT; the disease is Cirrhosis.